BiotechTV’s Brad Loncar interviews A. Katopodis on ways to solve T-cell exhaustion

 ANAVEON Biotech Cancer IL-2 Cytokines Bispecific Phase Clinical

For the full story, please, check out this link to Biotech TV and to find out more about Brad find him on LinkedIn.

Latest News

07.11.2024
Anaveon presents new data on development compounds ANV700 and ANV600 at the Society for Immunotherapy of Cancer 2024 Annual Meeting ANAVEON Biotech Cancer IL-2 Cytokines Bispecific Phase Clinical

Anaveon presents new data on development compounds ANV700 and ANV600 at the Society for Immunotherapy of Cancer 2024 Annual Meeting

Basel, Novmeber 9, 2024 – Anaveon, a clinical stage, immuno-oncology company, presents posters on ANV700 and ANV600 at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting being held from Friday, November 8, 2024, to Sunday, November 10, 2024, in Houston, Texas. Abstracts will…
Read more
30.10.2024
Anaveon announces presentation of new data on development compounds ANV700 and ANV600 at the Society for Immunotherapy of Cancer 2024 Annual Meeting ANAVEON Biotech Cancer IL-2 Cytokines Bispecific Phase Clinical

Anaveon announces presentation of new data on development compounds ANV700 and ANV600 at the Society for Immunotherapy of Cancer 2024 Annual Meeting

— First presentation of ANV700, a targeted IL-21 employing proximity activated potentiation of cytokine signaling — — New mechanistic data provide insights into the mode of action of ANV600, currently in clinical development — Basel, October 30, 2024 – Anaveon, a clinical stage, immuno-oncology company,…
Read more
07.10.2024
BiotechTV’s Brad Loncar interviews A. Katopodis on ways to solve T-cell exhaustion ANAVEON Biotech Cancer IL-2 Cytokines Bispecific Phase Clinical

BiotechTV’s Brad Loncar interviews A. Katopodis on ways to solve T-cell exhaustion

For the full story, please, check out this link to Biotech TV and to find out more about Brad find him on LinkedIn.
Read more
Corporate Positioning & Design, Concept, Webdesign & Code:
Schlatter corporate GmbH
Davidstrasse 45
CH-9000 St.Gallen
schlattercorporate.com
Our website uses cookies to provide you with the best online experience. By using our website, you accept the use of cookies in accordance with our Privacy Policy.
Accept